Mizojiri K et al. |
Disposition of S-1108, a new oral cephem antibiotic, and metabolic fate of pivalic acid liberated from [pivaloyl-14C]S-1108 in rats and dogs. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7492083
|
Diep QN et al. |
Formation of pivaloylcarnitine in isolated rat heart cells. |
1995 |
Biochim. Biophys. Acta |
pmid:7488636
|
Abrahamsson K et al. |
Effect of short-term treatment with pivalic acid containing antibiotics on serum carnitine concentration--a risk irrespective of age. |
1995 |
Biochem. Mol. Med. |
pmid:7551831
|
Abrahamsson K et al. |
Impaired ketogenesis in carnitine depletion caused by short-term administration of pivalic acid prodrug. |
1994 |
Biochem. Med. Metab. Biol. |
pmid:7917463
|
Fujii R et al. |
[Effect of cefditoren pivoxil on carnitine metabolism in pediatric patients]. |
1993 |
Jpn J Antibiot |
pmid:8254895
|
Shimizu K et al. |
Carnitine status and safety after administration of S-1108, a new oral cephem, to patients. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8517691
|
Melegh B et al. |
Preferential elimination of pivalate with supplemental carnitine via formation of pivaloylcarnitine in man. |
1993 |
Xenobiotica |
pmid:8310709
|
Wang SS et al. |
Cleavage and deprotection of peptides on MBHA-resin with hydrogen bromide. |
1992 Sep-Oct |
Int. J. Pept. Protein Res. |
pmid:1335998
|
Holme E et al. |
Effects of pivalic acid-containing prodrugs on carnitine homeostasis and on response to fasting in children. |
1992 |
Scand. J. Clin. Lab. Invest. |
pmid:1514015
|
Konishi M and Hashimoto H |
Determination of pivaloylcarnitine in human plasma and urine by high-performance liquid chromatography with fluorescence detection. |
1992 |
J Pharm Sci |
pmid:1432617
|